Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2008 12:10 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma's Plant-Produced Flu Subunit Vaccines Provide Protection in Preclinical Studies

HILLSIDE, N.J., April 30, 2008 (PRIME NEWSWIRE) -- InB:Biotechnologies, Inc., a wholly-owned subsidiary of Integrated BioPharma, Inc. (Nasdaq:INBP), announced today that prototypes of the Company's...
April 25, 2008 15:00 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma, Inc. Complies With Marketplace Rule 4350

HILLSIDE, N.J., April 25, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that it is in compliance with Marketplace Rule 4350. On February 21, 2008, the Company...
February 26, 2008 14:02 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Announces Appointments to Senior Management Group

HILLSIDE, N.J., Feb. 26, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that Carl DeSantis, the founder, principal owner and former Chairman and CEO of Rexall...
February 22, 2008 16:23 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2007 and Announces New $17.5 Million Financing

HILLSIDE, N.J., Feb. 22, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for the three and six month periods ended December 31, 2007. Revenues for...
November 14, 2007 13:15 ET | Source: Integrated BioPharma, Inc.

Integrated Biopharma, Inc. Names Robert L. Erwin as President of InB:Biotechnologies, Inc.

HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated Biopharma, Inc. (Nasdaq:INBP) today announced the appointment of Robert L. Erwin as President of its wholly-owned subsidiary,...
November 14, 2007 12:45 ET | Source: Integrated BioPharma, Inc.

Integrated Biopharma Executes Spin-Off Agreement

HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated Biopharma, Inc. (Nasdaq:INBP) announced today that its Board of Directors has approved the previously-announced spin-off of its...
November 14, 2007 12:10 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2007

HILLSIDE, N.J., Nov. 14, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for its first quarter ended September 30, 2007. Revenues for the quarter...
September 28, 2007 17:00 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Reports Results for Its Fiscal Year Ended June 30, 2007

HILLSIDE, N.J., Sept. 28, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) reported financial results today for its fiscal year ended June 30, 2007. Revenues were $60.2 million, an...
August 30, 2007 10:30 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Announces SEC Approval to Withdraw Registration Statement

HILLSIDE, N.J., Aug. 30, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced that the Securities and Exchange Commission (SEC) has approved the Company's application to...
August 14, 2007 09:30 ET | Source: Integrated BioPharma, Inc.

Integrated BioPharma Announces Novel Platform Technology With Multiple Product Leads

HILLSIDE, N.J., Aug. 14, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced that its subsidiary, InB:Biotechnologies, Inc. (InB:Bio) has developed what it believes is a novel,...